{
  "drug_name": "Cyclobenzaprine",
  "url": "https://wikem.org/wiki/Cyclobenzaprine",
  "scraped_at": "2026-01-10T07:51:20.376549",
  "sections": {
    "Toxicity": {
      "text": "Similar to\nTricyclic antidepressant toxicity\n, molecular structure similar and urine testing can be positive for TCAs\nCan have anticholinergic toxidrome in overdose",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Tricyclic antidepressant toxicity",
          "url": "https://wikem.org/wiki/Tricyclic_antidepressant_toxicity"
        }
      ]
    },
    "Administration": {
      "text": "Type: muscle relaxant\nDosage Forms:\nRoutes of Administration: Oral\nCommon Trade Names: Flexeril",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "5-10mg PO 1-3 times per day",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": ">15 y/o\n5-10 mg TID",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: B\nLactation risk\n: infant risk cannot be ruled out",
      "subsections": {
        "Renal_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Adult: Titrate slowly\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Renal_Dosing": {
      "text": "Adult:\nPediatric:",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "Adult: Titrate slowly\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "Adult: Titrate slowly\nPediatric:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nMAOI use, concomitantly or within 14 days\nHeart block or other serious arrhythmias, CHF",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Neuroleptic malignant syndrome\nSerotonin syndrome\nStroke\nDysrhythmias, heart block\nBone marrow depression\nHepatitis",
          "tables": []
        },
        "Common": {
          "text": "Somnolence, dizziness\nNausea, constipation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Neuroleptic malignant syndrome\nSerotonin syndrome\nStroke\nDysrhythmias, heart block\nBone marrow depression\nHepatitis",
      "subsections": {
        "Common": {
          "text": "Somnolence, dizziness\nNausea, constipation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Somnolence, dizziness\nNausea, constipation",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: ~18h for immediate release, 32h for extended release\nMetabolism: hepatic\nExcretion: Urine",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Acts on CNS to reduce tonic somatic motor activity",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}